Hepatitis C virus inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S153000, C548S531000

Reexamination Certificate

active

07323447

ABSTRACT:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which inhibit the function of the NS3 protease (also referred to herein as “serine protease”) encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS3 protease.

REFERENCES:
patent: 6268207 (2001-07-01), Bailey
patent: 2005/0153877 (2005-07-01), Miao et al.
patent: 2006/0172950 (2006-08-01), Wang et al.
patent: 2006/0199773 (2006-09-01), Sausker et al.
patent: WO 98/17679 (1998-04-01), None
patent: WO 98/46597 (1998-10-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 2004/103996 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 03/064416 (2003-01-01), None
patent: WO 03/053349 (2003-07-01), None
patent: WO 03/064416 (2003-07-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 03/064456 (2003-08-01), None
patent: WO 03/066103 (2003-08-01), None
patent: WO 03/099274 (2003-12-01), None
patent: WO 03/099316 (2003-12-01), None
patent: WO 2004/009121 (2004-01-01), None
patent: WO 2004/032827 (2004-04-01), None
patent: WO 2004/037855 (2004-05-01), None
patent: WO 2004/043339 (2004-05-01), None
patent: WO 2004/072243 (2004-08-01), None
patent: WO 2004/093798 (2004-11-01), None
patent: WO 2004/093915 (2004-11-01), None
patent: WO 2004/094452 (2004-11-01), None
patent: WO 2004/101602 (2004-11-01), None
patent: WO 2004/101605 (2004-11-01), None
patent: WO 2004/113365 (2004-12-01), None
patent: WO 2005/010029 (2005-02-01), None
patent: WO 2005/028501 (2005-03-01), None
patent: WO 2005/037214 (2005-04-01), None
patent: WO 2005/037860 (2005-04-01), None
patent: WO 2005/046712 (2005-05-01), None
patent: WO 2005/051410 (2005-06-01), None
patent: WO 2005/051980 (2005-06-01), None
patent: WO 2005/054430 (2005-06-01), None
patent: WO 2005/070955 (2005-08-01), None
patent: WO 2005/073216 (2005-08-01), None
patent: WO 2005/095403 (2005-10-01), None
patent: WO 2005/116054 (2005-12-01), None
patent: WO 2006/000085 (2006-01-01), None
patent: WO 2006/007700 (2006-01-01), None
patent: WO 2006/007708 (2006-01-01), None
patent: WO 2006/016930 (2006-02-01), None
patent: WO 2006/020276 (2006-02-01), None
patent: WO 2006/026352 (2006-03-01), None
patent: WO 2006/033878 (2006-03-01), None
patent: WO 2006/043145 (2006-04-01), None
patent: WO 2006/096652 (2006-09-01), None
patent: WO 2006/119061 (2006-11-01), None
patent: WO 2006/122188 (2006-11-01), None
U.S. Appl. No. 11/415,722, filed May 2, 2006, Wenying Li.
U.S. Appl. No. 11/481,536, filed Jul. 6, 2006, Hewawasam, et al.
Lauer, G.M. and Walker, B.D., “Hepatitis C Virus Infection”,N. Engl. J. Med., 2001, 345, 41-52.
Poupart, M.-A., Cameron, D.R., Chabot, C., Ghiro, E., Goudreau, N., Boulet, S., Poirier, M., and Tsantrizos, Y.S., “Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease”,J. Org. Chem., 2001, 66, 4743-4751.
U.S. Appl. No. 11/591,253, filed Nov. 1, 2006, D'Andrea, et al.
Montse Llinas-Brunet, et al, “A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors,” J. Med. Chem., 47, pp. 6584-6594, 2004.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2797899

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.